跳至主要内容
临床试验/NCT02741219
NCT02741219已完成4 期

A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section

Obstetrics & Gynecology Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
225
试验地点
1
主要终点
Changes in pain score

研究概览

简要总结

The purpose of this multicenter study is to evaluate the effectiveness and safety of dexmedetomidine combined with sufentanil for patient-controlled analgesia after caesarean section

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Parturients undergoing elective caesarean delivery under spinal anaesthesia
  • American Society of Anesthesiologists class I and II parturients aged 18-45 years, with term singleton pregnancies
  • Parturients with the ability to understand verbal and written mandarin
  • Parturients who want to use PCA intravenous analgesia and can use the pump correctly
  • Parturients whose written informed consent have been obtained

排除标准

  • A history of allergy to dexmedetomidine or other study drugs
  • A long use history of opioid analgesic, NSAIDs, tranquilliser use
  • Psychiatric disorders
  • A history of neuromuscular and endocrine disease or allergic disease
  • A history of lower abdominal surgery
  • Preoperative heart rate (HR) less than 50 bpm, SBP less than 100 mmHg or cardiac conduction or rhythm abnormalities
  • spinal anaesthesia was unsuccessful or an epidural catheter had to be used to achieve adequate anaesthesia
  • A second operation is required during the study.
  • Participating other study during the latest three months
  • Body mass index more than 30 kg/m2
  • Difficult airway ( Mallampati score more than 3 and anatomic deformity )
  • Not suitable for participation estimated by investigation

研究组 & 干预措施

Control Group

Placebo Comparator

Parturients in this group receive 20ml intravenous normal saline immediately after delivery. Their patient controlled analgesia (PCA) protocol after surgery consists of 100 mcg sufentanil diluted into 100ml and administer at a background infusion of 1ml/h,and a bolus of 2ml, with a lock-out of 8min.

干预措施: Normal saline (Drug)

Control Group

Placebo Comparator

Parturients in this group receive 20ml intravenous normal saline immediately after delivery. Their patient controlled analgesia (PCA) protocol after surgery consists of 100 mcg sufentanil diluted into 100ml and administer at a background infusion of 1ml/h,and a bolus of 2ml, with a lock-out of 8min.

干预措施: Sufentanil (Drug)

Dex Group

Experimental

Parturients in this group receive 0.5mcg/kg intravenous dexmedetomidine diluted to 20ml with normal saline. Their PCA protocol after surgery is 100mcg sufentanil and 300mcg dexmedetomidine diluted to 100ml in saline, with the continuous infusion of 1ml/h, and a bolus of 2 ml, with a lock-out of 8min.

干预措施: Dexmedetomidine (Drug)

Dex Group

Experimental

Parturients in this group receive 0.5mcg/kg intravenous dexmedetomidine diluted to 20ml with normal saline. Their PCA protocol after surgery is 100mcg sufentanil and 300mcg dexmedetomidine diluted to 100ml in saline, with the continuous infusion of 1ml/h, and a bolus of 2 ml, with a lock-out of 8min.

干预措施: Sufentanil and dexmedetomidine (Drug)

结局指标

主要结局

Changes in pain score

时间窗: At 0, 4, 8 and 24 h after surgery

Pain scores at rest and movement are evaluated with a visual analogue scale (VAS).

Sufentanil consumption

时间窗: During 24h after surgery

The total consumption of sufentanil during 24h after surgery are recorded.

次要结局

  • Changes in heart rate (HR)(At 0 min, 5 min, 10 min, 30 min after intervention during surgery and at 8h,24 h after surgery)
  • Changes in systolic blood pressure(At 0 min, 5 min, 10 min, 30 min after intervention during surgery and at 8h,24 h after surgery.)
  • Changes in Ramsay sedation score (RSS)(At 4, 8 and 24 h after surgery)
  • Press times of analgesic pump(During 24h after surgery)
  • Changes in saturation of blood oxygen (SpO2)(At 0 min, 5 min, 10 min, 30 min after intervention during surgery and at 8h,24 h after surgery)
  • Changes in diastolic blood pressure(At 0 min, 5 min, 10 min, 30 min after intervention during surgery and at 8h,24 h after surgery)
  • Changes in mean arterial blood(At 0 min, 5 min, 10 min, 30 min after intervention during surgery and at 8h,24 h after surgery)

研究者

发起方
Obstetrics & Gynecology Hospital of Fudan University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nie Yuyan

Associate Professor

Obstetrics & Gynecology Hospital of Fudan University

研究点 (1)

Loading locations...

相似试验

A Multicenter Study: Dexmedetomidine Combined With... | 临床试验